CH210424A - Process for the production of eriodictyol glucoside. - Google Patents

Process for the production of eriodictyol glucoside.

Info

Publication number
CH210424A
CH210424A CH210424DA CH210424A CH 210424 A CH210424 A CH 210424A CH 210424D A CH210424D A CH 210424DA CH 210424 A CH210424 A CH 210424A
Authority
CH
Switzerland
Prior art keywords
eriodictyol
production
glucoside
parts
acetone
Prior art date
Application number
Other languages
German (de)
Inventor
Aktiengesellsc Farbenindustrie
Original Assignee
Ig Farbenindustrie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ig Farbenindustrie Ag filed Critical Ig Farbenindustrie Ag
Publication of CH210424A publication Critical patent/CH210424A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

  

  Verfahren zur Herstellung von     Eriodictyolglukosid.       Bekanntlich besitzen     Glykoside    von     Poly-          ogyflavanonen    wegen ihrer physiologischen  Wirkung Interesse. Derartige Verbindungen  wurden bisher aus Früchten gewonnen.  



  Es wurde nun gefunden, dass man zu  wirksamen     Glykosiden    . von     Polyogyflava-          nonen    dadurch gelangen kann, dass man die  auf synthetischem Wege zugänglichen     Poly-          oxyflavanone    oder die     teilweise        verätherten     Derivate dieser     Verbindungen        in    die zuge  hörigen     Glykoside    überführt.  



  Das vorliegende Patent bezieht sich auf  ein Verfahren zur Herstellung von     Eriodic-          tyolglukosid,    welches dadurch gekennzeich  net ist, dass man ein     Alkalisalz    des     Eriodie-          tyols    mit einer     Acetohalogenglukose,    insbe  sondere mit     Acetobromglukose,    zur Umset  zung bringt und     aus    dem so erhaltenen     Ace-          tylglukosid    mit Hilfe eines alkalisch reagie  renden Mittels, beispielsweise mit Hilfe von  Natronlauge oder Ammoniak, die     Acetyl-          gruppen    abspaltet,    Die .

   neue Verbindung entspricht der  Formel:  
EMI0001.0027     
    Sie ist wegen ihrer physiologischen Wirk  samkeit von Interesse und soll für therapeu  tische Zwecke     Verwendung        finden.    Sie bil  det ein in Wasser, Methylalkohol und     Äthyl-          alkohol    leicht, in Aceton schwerer, in Äther,  Chloroform und Benzol kaum lösliches, gel  bes Pulver.  



  <I>Beispiel:</I>  92 Gewichtsteile     Eriodictyol.    werden in  einer     Stickstoffatmosphäre    in 1000     Volum-          teilen    Aceton und 320     Volumteilen        n-Na-          tronlauge    gelöst.

   Dazu     gibt    man allmählich      unter Rühren gleichzeitig eine Lösung von  140 Gewichtsteilen     Acetobromglulz:ose    in  560     Volumteilen    Aceton und     320        Volum-          teilen        n-Natronlauge.    Nach 5 bis 6 Stun  den wird mit Essigsäure angesäuert, in Es  sigester eingetragen, mit Wasser und dar  nach mit einer     Bikarbonatlösung    ausgeschüt  telt und die     Essigesterlösung    getrocknet.

    Nach dem Behandeln mit Kohle wird ein  gedampft, der     Rückstand    mit Chloroform  aufgenommen, wobei das nicht umgesetzte       Eriodictyol    ungelöst bleibt, und die Lösung  in     Gasolin    eingetragen. Das so erhaltene       Tetraacetylglukosid    bildet ein schwach gel  bes, in Alkohol leicht lösliches Pulver.  



  49,4 Gewichtsteile obiger     Tetraacetylver-          bindung    werden unter Stickstoff in 1500       Volumteilen        n-Natronlauge    gelöst, nach  2 Stunden mit 1500     Volumteilen        n-Scli#,vefel-          säure    versetzt, mit Kohle behandelt und im  Vakuum eingedampft. Der erhaltene Rück  stand wird mit Methanol ausgezogen und die  Lösung wiederum eingedampft. Der erhal  tene     Extraktionsrückstand    wird in wenig ab  solutem Alkohol gelöst, mit Aceton versetzt,    mit Kohle     geklärt    und durch     Äther    gefällt.

    Die neue Verbindung bildet ein in Wasser,       Methylalkohol    und     Ethylalkohol    leicht, in  Aceton schwerer, in     A-ther,    Chloroform und  Benzol kaum lösliches gelbes Pulver.



  Process for the production of eriodictyol glucoside. It is known that glycosides of polyogyflavanones are of interest because of their physiological action. Such compounds have previously been obtained from fruits.



  It has now been found that one can produce effective glycosides. from polyogyflavanones can be obtained by converting the synthetically accessible polyoxyflavanones or the partially etherified derivatives of these compounds into the associated glycosides.



  The present patent relates to a process for the production of eriodictyol glucoside, which is characterized in that an alkali salt of eriodietyol is reacted with an acetohalogenglucose, in particular with acetobromoglucose, and from the acetylglucoside obtained in this way with the help of an alkaline reacting agent, for example with the help of sodium hydroxide solution or ammonia, which splits off the acetyl groups.

   new compound corresponds to the formula:
EMI0001.0027
    It is of interest because of its physiological efficacy and should be used for therapeutic purposes. It forms a yellow powder that is easily soluble in water, methyl alcohol and ethyl alcohol, more difficult in acetone, and hardly soluble in ether, chloroform and benzene.



  <I> Example: </I> 92 parts by weight of eriodictyol. are dissolved in 1000 parts by volume of acetone and 320 parts by volume of n-sodium hydroxide solution in a nitrogen atmosphere.

   To this end, a solution of 140 parts by weight of acetobromo glulz: ose in 560 parts by volume of acetone and 320 parts by volume of n-sodium hydroxide solution is gradually added simultaneously with stirring. After 5 to 6 hours the acid is acidified with acetic acid, added to Es sigester, extracted with water and then with a bicarbonate solution and the ethyl acetate solution is dried.

    After the treatment with charcoal, it is evaporated, the residue is taken up with chloroform, the unreacted eriodictyol remaining undissolved, and the solution is introduced into gasoline. The tetraacetyl glucoside obtained in this way forms a pale yellow powder that is easily soluble in alcohol.



  49.4 parts by weight of the above tetraacetyl compound are dissolved under nitrogen in 1500 parts by volume of n-sodium hydroxide solution, after 2 hours 1500 parts by volume of n-sodium hydroxide are added, treated with charcoal and evaporated in vacuo. The residue obtained is extracted with methanol and the solution is again evaporated. The extraction residue obtained is dissolved in a little absolute alcohol, mixed with acetone, clarified with charcoal and precipitated with ether.

    The new compound forms a yellow powder which is easily soluble in water, methyl alcohol and ethyl alcohol, more difficult in acetone, and hardly soluble in ether, chloroform and benzene.

 

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von Eriodie- ty olglukosid, dadurch gekennzeichnet, dass man ein Alkalisalz des Eriodictvols mit einer Acetohalogenglukose zur Umsetzung bringt und aus dem so erhaltenen Acetyl- g1uhosid mit Hilfe eines alkalisch reagieren den Mittels die Acetylgruppen abspaltet. PATENT CLAIM: A process for the production of eriodiety olglucoside, characterized in that an alkali salt of Eriodictvol is reacted with an acetohalogenglucose and the acetyl groups are split off from the acetylg1uhoside thus obtained with the aid of an alkaline agent. Die neue Verbindung bildet ein in Was ser, 3lethylalliohol und Ethylalkohol leicht., in Aceton schwerer, in Xtlier, Chloi,oform und Benzol kauiu lösliches gelbes Pulver. <B>UNTERANSPRUCH:</B> Verfahren nach Patentanspruch, dadurch gekennzeichnet, dass man als Aeetohalogen- glukose die Acetobi-omglukose verwendet. The new compound forms a yellow powder which is easily soluble in water, ethylalliol and ethyl alcohol, more difficult in acetone, and kauiu in Xtlier, Chloi, oform and benzene. <B> SUBCLAIM: </B> Process according to patent claim, characterized in that acetobromglucose is used as the aetohalogenglucose.
CH210424D 1936-12-24 1937-12-20 Process for the production of eriodictyol glucoside. CH210424A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE215341X 1936-12-24

Publications (1)

Publication Number Publication Date
CH210424A true CH210424A (en) 1940-07-15

Family

ID=96230377

Family Applications (2)

Application Number Title Priority Date Filing Date
CH210424D CH210424A (en) 1936-12-24 1937-12-20 Process for the production of eriodictyol glucoside.
CH215341D CH215341A (en) 1936-12-24 1937-12-20 Process for the preparation of Eriodictyol-Cellobiosid.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH215341D CH215341A (en) 1936-12-24 1937-12-20 Process for the preparation of Eriodictyol-Cellobiosid.

Country Status (1)

Country Link
CH (2) CH210424A (en)

Also Published As

Publication number Publication date
CH215341A (en) 1941-06-15

Similar Documents

Publication Publication Date Title
DE1518002C3 (en) Isoflavans and isoflavens and processes for their production and medicinal products containing them
EP0306651A1 (en) Process for the preparation of alkyloligoglycosides
DE964680C (en) Process for the production of high molecular weight phosphoric acid esters of hydroxyl group-containing flavone or flavanone derivatives
CH210424A (en) Process for the production of eriodictyol glucoside.
DE3032795C2 (en) Disinfectant based on glutaraldehyde substituted in the 2-position
AT157720B (en) Process for the production of glucosides.
DE2016704C3 (en) A new, 14.15 ß-Oxidobufadienolide-LRhamnoside, active in the heart, and process for its preparation
DE745561C (en) Process for the preparation of glycosides and glycoside-like compounds
DE1018874B (en) Process for the preparation of N-substituted 2-methyl-7-aminoalkoxy-chromones
DE710966C (en) Process for the preparation of oxycarboxylic acid esters of the oestrone series
DE965637C (en) Process for the preparation of 19-nortestosterone-17-acylates and / or their 3-enol acylates
DE964328C (en) Process for the production of crystallized vanillylamides
DE728360C (en) Process for the preparation of a trisubstituted barbituric acid
AT217994B (en) Process for the preparation of new derivatives of polyhydroxy alcohols
AT263814B (en) Process for the production of a new poly-γ-propylsulfonic acid ether of inulin
DE756003C (en) Process for the preparation of new derivatives of compounds of the adrenal cortex hormone series
DE956047C (en) Process for the production of furano (4 &#39;, 5&#39;: 6, 7) chromones
DE1468554C (en) 20 beta tert amino 3 alpha hydroxy (or acyloxy) 5 beta pregnane or its salts and processes for their manufacture
CH301688A (en) Process for the preparation of a new aromatic thioether.
CH314798A (en) Process for the preparation of durable, injectable solutions of 1-phenyl-2,3-dialkyl-4-dialkylamino-5-pyrazolones
CH301700A (en) Process for the preparation of a new aromatic thioether.
DE1966821B2 (en) and its acid addition salts
CH520132A (en) Oestrogen water-soluble conjugates
DE1122514B (en) Process for the preparation of hypertensive 2-AEthyl-3,3-diphenyl-propen- (2) -yl-amine
DE1119267B (en) Process for the preparation of gonad-inhibiting derivatives of 17-epi-oestriol